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Introduction 
Symptoms, Function, or Anatomy as Criteria of 
Restenosis? The incidence of late restenosis has 
remained much the same over the 13 years that 
angioplasty has been part of clinical practice and 
there is still no proven intervention that modifies 
the restenosis process.' 
Primary success and restenosis after percuta- 
neous transluminal coronary angioplasty (PTCA) 
may be defined by symptomatic criteria such as 
frequency and severity of anginal episodes, by 
functional criteria such as pressure flow charac- 
teristic of the dilated vessel, coronary flow re- 
serve and various noninvasive diagnostic tests, 
or may be defined by anatomic criteriausing post- 
mortem histology, angiography, or intervascular 
ultrasound. These three criteria may be consid- 
ered separately or may be interrelated so that the 
definition of restenosis becomes a complex issue. 
About the symptomatic criteria, it is fair to em- 
phasize the four following points. ( 1 )  Although 
the subjective improvement of symptoms after 
PTCA is probably the most desirable endpoint, 
it is also the least objective evaluation.2 (2) The 
frequency of symptomatic improvement appears 
to be lower than that of angiographic success: 
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only 80%-85% of the patients with a satisfactory 
angiography result immediately post-PTCA ex- 
hibit such an i m p r ~ v e m e n t . ~  ( 3 )  The reappear- 
ance of angina as a sole criterion of restenosis 
underestimates the angiographic rate of resteno- 
sis. The reported incidence of silent restenosis 
may be as high as 33%. (4) However, the elapsed 
time from PTCA to recurrence of symptoms has 
shown to be clinically useful in identifying the 
most probable cause of recurrent angina: 
-Within 1 month: incomplete revascularization 
from additional coronary artery disease and/or 
incomplete dilatation should be suspected. 
-Within 1-6 months: restenosis, that is to say, 
lesion recurrence is most likely. 
-After 6 months: new significant atherosclerosis 
disease should be ~ o n s i d e r e d . ~  
The value of recurrent anginal symptoms as a 
marker of restenosis is difficult to assess in many 
studies because the timing and completeness of 
angiographic follow-up often have been deter- 
mined by symptomatic status. In studies with a 
high rate of angiographic follow-up, the probabil- 
ity that patients with symptoms had restenosis 
(i.e., the positive predictive value of symptoms) 
ranged from 48%-92%, whereas the probability 
that patients without symptoms were free of re- 
stenosis (i.e., the negative predictive value of 
symptoms) range from 70%-98% (Table l ) . 5  
The low positive predictive value found in 
many of these studies may be explained by the 
presence of other mechanism for angina, such as 
incomplete revascularization or progress of dis- 
ease in other vessels. 
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Table 1. Detection of Restenosis by Symptoms 
Symptoms 
Follow-Up Restenosis PPV NPV 
Angiograp hic 
Author Year % % % %  
Simonton ’88 90 35 48 75 
Califf ’90 100 38 60 85 
Zaidi ’85 100 49 66 70 
Mabin ’85 55 32 71 86 
Levine ’85 92 40 76 96 
Jutzy ‘82 88 47 92 83 
Gruentzig ’87 93 31 92 98 
Modified from Califf et 
NPV = negative predictive value. 
PPV = positive predictive value: 
Several studies have examined the ability of the 
exercise treadmill test to detect restenosis after 
PTCA. These studies have generally found that 
the presence of exercise-induced angina or ST 
segment depression or both is not highly predic- 
tive of restenosis whether the test is performed 
early or late after angioplasty. The positive pre- 
dictive values of early treadmill testing range 
from 29%-60%, whereas the corresponding val- 
ues for late treadmill testing are ranging from 
39%-64% (Table 2). The low positive predictive 
value is most likely a consequence of incomplete 
revascularization: that is either a totally occluded 
vessel, or a significant stenosis at a site other than 
dilated by angioplasty. It is also possible that the 
noninvasive test is accurately demonstrating a 
functionally inadequate dilatation, despite the ap- 
pearance of success on angiography. 
Table 3 shows the accuracy of thallium scintig- 
raphy for detection of restenosis in series, which 
have a reasonable angiographic follow-up ranging 
from 55%- 100%. Since cardiac catherization re- 
mains “the gold standard” for detection of reste- 
nosis, the reported value of a noninvasive tests is 
determined not only by the actual accuracy of the 
test but also by the completeness of angiographic 
follow-up. In these studies with a high rate of an- 
giographic follow-up the positive predictive value 
of thallium scintigraphy is ranging between 56% 
and 89%. 
Recently, Lefkowitz et aL6 have shown that the 
positive and negative predictive values for tomo- 
graphic imaging in detection of restenosis were 
superior to the predictive values observed with 
planar imaging. In addition, the specific vascular 
territory was correctly localized to the PTCA ter- 
ritory in 77% of the tomographic studies. 
Coronary Angiography Still “the Gold Stan- 
dard”. In view of the above, coronary angio- 
graphy still is the most reliable method ofjudging 
the late results. Unfortunately, there are many 
studies on coronary restenosis reported that are 
distinguished by their lack of consistency in their 
methodological approach and their definitions of 
restenosis. Figure 1 illustrates this point. On the 
vertical axis of this “nonscientific” figure, we 
have the names of the investigators, who have 
studied the restenosis problem, on the horizontal 
axis we have the restenosis rate observed in their 
studies. A restenosis rate ranging between 25% 
and 35% seems to emerge. However, we have to 
Table 2. Detection of Restenosis by Exercise Treadmill Testing 
Angiographic 
Follow-Up Restenosis PPV NPV 
Author % % %: % Timing of Test 
O’Keefe 
Scholl 
Wins* 
Wins* 
Bengston 
Rosing 
Ernst 
Honan 
Scholl 
100 
83 
74 
89 
96 
100 
100 
88 
83 
13 
12 
35 
40 
51 
34 
4 
58 
12 
29 
40 
50 
60 
39 
47 
50 
57 
64 
73 
27 
65 
52 
84 
76 
95 
64 
50 
< 1 month 
1 month 
3-1 weeks 
3-8 weeks 
6 months 
8 months 
4-8 months 
6 months 
6 months 
Modified from Califf et al.5 PPV = positive predictive value; NPV = negative predictive value 
* Thoraxcenter. 
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Table 3. Detection of Restenosis by Thallium 201 Scintigraphy 
Angiographic 
FoIIow-UP Restenosis PPV NPV 
Author % 9% 9% % Timing of Test 
_ _  
-- 
-- 
-- 
-- 
-- 
-- 
-- 
-- 
Jain 
Miller 
Lam 
Wins* 
Wijns" 
Scholl 
Ernst 
Rosing 
Lefkowitz 
55 
76 
100 
74 
89 
83 
100 
100 
planar thallium 
tomographic thallium 
14 
39 
9 
35 
40 
12 
4 
21 
79 88 
76 94 
89 96 
14 83 
82 72 
56 42 
100 15 
50 100 
37 83 
62 80 
80 93 
0-6 days 
2 weeks 
2 weeks 
3-7 weeks 
3-8 weeks 
1 months 
6 months 
4-8 months 
8 months 
6 months 
Modified from Califf et al.' PPV = positive predictive value; NPV = negative predictive value. 
* Thoraxcenter 
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Figure 1. Restenosis rates found by different authors, applying I 1  different restenosis criteria, different angiographic follow- 
up (Fiti) times (1-9 months), and different analysis techniques (visual or quantitative). 
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Table 4. Criteria of Restenosis in Current Use 
1. Loss of at least 50% of the initial gain (NHLBI 4) 
2. A return to within 10% of the pre-PTCA diameter 
3 .  An immediate post-PTCA < 50% diameter stenosis 
4. As for 3, but for a diameter stenosis E 70% at 
5 .  Reduction --i 20% in diameter stenosis 
6 .  Reduction 2 30% in diameter stenosis (NHLBI 1) 
7. A diameter stenosis 2 50% at follow-up 
8. A diameter stenosis 2 70% at follow-up 
9. Area stenosis E 85%14 
stenosis (NHLBI 3 )  
that increases to 2 50% at follow-up 
follow-up (NHLBI 2) 
10. Loss 2 1 mmz in stenosis areal5 
11. Deterioration of 2 0.72 mm in minimal luminal 
diameter from post-PTCA to f o l l ~ w - u p ’ ~  
12. Deterioration of t 0.5 mm in minimal luminal 
diameter from post-PTCA to follow-up’* 
NHLBI = National Heart Lung Blood Institute: PTCA = 
percutaneous transluminal coronary angioplasty . 
emphasize the following facts: the angiographic 
follow-up in these patients range between 57% 
and loo%, the time to follow-up range between 1 
and 9 months, and 11 different criteria of resteno- 
sis have been applied by these investigators who 
in large majority used visual assessment of the 
coronary angiogram. 
The variety of criteria in current use is tabu- 
lated in Table 4. Most are entirely arbitrary, some 
arc based on doubtful logic and some, although of 
some relevance for visual estimation of percent 
diameter stenosis, are unrealistic when applied to 
the most accurate values obtained from quantita- 
tive angiography. Thus, most of the discrepancies 
between these studies can be attributed to three 
factors: (1) the selection of patients, (2) the 
method of analysis, and (3) the definition of reste- 
nosis used. In order to improve the situation 
these three factors need to be addressed.’ 
1. The study population. This means a high an- 
giographic follow-up rate (> 80%) with a prede- 
termined time for restudy, this will avoid a selec- 
tion bias of symptomatic patient. Sample size of 
observational or randomized clinical trial should 
be adequately controlled to avoid a type I1 error 
commonly referred to as the power of the test. 
2. A well validated system of analysis with 
known accuracy and variability should be used. 
The use of a visual percent diameter stenosis 
SERRUYS, ET AL. 
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measurement with its inherent variability pre- 
cludes meaningful results and edge tracing by 
hand or other techniques that can produce values 
not physiologically possible are also unaccepta- 
ble.* Video densitometry may eventually provide 
the best measurement because the technique esti- 
mates the volume of the lumen independently of 
geometric assumption, but for technical reason 
this theoretical method of choice has not (yet) 
proven practical. 
3.  The measured variables must be chosen so 
as to  reflect the restenosis proliferative process 
and distinguish between the results of angio- 
plasty (optimal or suboptimal) and this prolifera- 
tive restenosis process. We believe that the con- 
ventional assessment of percent diameter steno- 
sis is not sufficiently discriminating in doing this 
and that definitions based on percent diameter 
stenosis measurement fail to identify lesions 
undergoing significant deteri~ration.’”~ Percent 
diameter stenosis criteria are chosen to reflect the 
change in minimal luminal diameter in relation to 
the so-called normal diameter of the vessel in the 
immediate vicinity of the obstruction. In the first 
place it is assumed that there is a normal diame- 
ter; diffuse intimal or subintimal thickening are 
not detectable on a coronary “shadowgram.” 
Second, the choice of a so-called normal diame- 
ter, proximal or distal to the obstruction is arbi- 
trary and will have major impact on the calcula- 
tion of the percentage diameter stenosis. This is 
illustrated in Figure 2; in this particular example 
the percentage diameter stenosis is ranging from 
75%-60% according to the site of reference arbi- 
trarily chosen. Third, it is assumed that this nor- 
mal diameter does not change as a result of angio- 
plasty or during the immediate follow-up period 
when restenosis of the dilated lesion is a well rec- 
ognized phenomenon. The so-called normal di- 
ameter might be diffusely affected by the baro- 
trauma of the balloon that can induce a reactive 
hyperplasia in the area touched by the balloon. l o  
This seriously questions the use of percent diame- 
ter stenosis as the only index of restenosis (Fig. 
3). 
Restenosis Definition, Subject to Debate. The re- 
stenosis definition of choice has been the subject 
of much debate and there is currently no satisfac- 
tory definition that takes into account the func- 
DEFINITION OF RESTENOSIS AFTER PTCA 
6 6 '/o 6 0 O/O 75% D Sten 
USER DEFINED 
PROX. REF. DIAM. 
USER DEFINED 
DIST. REF. DIAM. 
Figure 2. Graphical illustration of different percentage diameter stenosis values dependent on the arbitrary choice of the site of 
the reference diameter. With our quantitative analysis system it is possible to obtain an objective, independent value for the 
reference diameter and thus, for the percent diameter stenosis. This is called the "interpolated reference diameter." A computer 
derived reconstruction of the original arterial dimension at the sitc of obstruction (assuming there is no disease prcsent) is used 
to define the interpolated reference diameter (tapering lines in figure). 
tional and angiographic outcome after PTCA. 
The known discrepancy between these two pa- 
rameters means that this objective will not be re- 
alized. A single "stenosis" measurement should 
not be confused with a measurement of "resteno- 
sis," which should represent the change in steno- 
sis severity. The commonly used definition of 
50% diameter stenosis at follow-up is historically 
based on the physiological concept of coronary 
flow reserve introduced by Lance Could" in 1974 
and is taken because it represents the approxi- 
mate value in animals with normal coronary arter- 
ies at which blunting of the hyperemic response 
occurs. Although this value may be of some rele- 
vance in determining a significant stenosis in 
human atherosclerotic vessels, it tells us nothing 
about the way the lesion has behaved since the 
angioplasty procedure. 
In 1988, two different studies, performing fol- 
low-up angiography at different preselected fol- 
low-up intervals, gave remarkably similar results 
and showed more precisely how lesions behave 
after angioplasty. 12,13 In a study carried out at the 
Thoraxcenter the minimal lumen diameter mea- 
sured increased slightly from 2.06 mm to 2. l l mm 
at 30 days and then decreased steadily to 1.93, 
1.77, and 1.69 mm at the subsequent follow-up 
times (2, 3, and 4 months). Nobuyoshi and col- 
leagues restudied 229 patients at 24 hours, and 1 ,  
3, 6, and 12 months. Their findings were very 
similar to ours (Fig. 4). In addition, it should be 
stressed that the individual changes in minimal 
luminal diameter of these lesions show that it is 
not just a limited number of lesions that "reste- 
nose," but rather almost all lesions deteriorate to 
some extent. This is a concept that is not well 
understood in the context to restenosis. A signifi- 
cant deterioration is also seen in the decreasing 
reference diameter that tends to minimize the 
change in the calculated percentage diameter ste- 
nosis. Furthermore, lesion progression after 6 
months is unusual. l 2  
While accurate (quantitative) asscssment sug- 
gests that the trend to restenosis applies to most 
dilated lesions, deciding which of these lesions 
should be defined as restenosis is less clear. In- 
deed, the factor that most influences the resteno- 
sis rate is the definition of restenosis applied. Fig- 
ure 5 shows the incidence ofrestenosis according 
to three criteria taken from a group of 490 lesions 
analyzed in the first 150 days after angioplasty; l 3  
the three criteria are the National Heart Lung 
Blood Institute criterion 4: a loss of greater than 
half the gain, a diameter >SO% at follow-up and 
a change X . 7 2  mm from postangioplasty to fol- 
low-up. From this figure two conclusions can be 
drawn: first, there is a variation in the incidence 
of restenosis according to the criterion applied, 
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Figure 3. Single frame angiograms of a proximal left anterior descending artery stenosis. (A) Predilation 
(pre-PTCA), (B) postdilation (post-PTCA), and (C) at follow-up. Quantitative coronary analysis was per- 
formed using a coronary angiography analysis system. The arterial boundaries detected by the system are 
shown on the angiogram and below the diameter function curve derived from these contours. The example 
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Figure 4. Minimal luminal diameter (MLD) and reference diameter (KD) values found in the studies by Nobuyoshi 
et a l .”  and Serruys et al.’? Results are remarkably similar. 
and second, the incidence of restenosis is pro- 
gressive to at least the third month. At 5 months. 
the incidence of restenosis is not too dissimilar, 
ranging from 21%-34%. However, it should be 
clear that even a similar incidence of restenosis 
using different criteria may be defining different 
patients. This is illustrated by Figure 6, which 
shows a Venn diagram of the number of lesions 
fulfilling three different restenosis criteria, taken 
from the same group of 490 lesions.’3 The 43 le- 
sions that fulfill each criterions are enclosed by all 
three circles. Although the percentages of lesion, 
fulfilling the three criteria for restenosis were sim- 
ilar, it must be emphasized that each of the three 
criteria identified unique lesions that were not 
identified by the other two. This point has a par- 
illustrates the importance of the choice of reference diameter, the fact that the dilated but nonstenotic 
coronary artery may be involved in the restenosis process. and the value of the interpolated reference 
diameter for calculating the appropriate diameter stenosis. (A) Before angioplasty, the lesion is relatively 
easy to analyze. The segments proximal and distal to the stenosis are of similar caliber and the lesion is 
relatively discrete, so that its length can easily be defined on  the diameter function curve. (B) After 
angioplasty, there is a satisfactory result. the diameter stenosis decreasing from 59% to 36% (area stenosis 
from 83% to 59%). (C) At follow-up. the result is dependent on the method of analysis. The artery proximal 
to the stenosis has already been involved in the restenosis process; if this is chosen as  a reference diameter 
(left). a 42% diameter stenosis is obtained (no “restenosis”). The distal portion is of a larger caliber than 
the proximal portion; if it is chosen as  a reference diameter (middle), the result is a 62% diameter stenosis 
(“restenosis”). If the interpolated technique i3 used (right), the reference diameter is similar to the postan- 
gioplasty value, and a 58%) diameter stenosis is obtained that accurately reflects what is happening between 
the postangioplasty result and the follow-up. Even with this high quality angiogram of a well visualized 
segment with a discrete stenosis, there are problems in obtaining accurate and realistic results. 
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Figure 5. Restenosis rates at 1,2,  3,4 ,  and 5 months (M) follow-up after PTCA, applying three different restenosis 
criteria.I3 NHLBI 4 = National Heart Lung Blood Institute criterion 4, REST RATE = restenosis rate. 
50% DS 
(N.67) 
2: 0.72 mm 
(N=80) 
Figure 6 .  Venn diagram showing the number of lesions fulfilling three different restenosis criteria.” 
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ticular relevance when determining the risk fac- 
tors for restenosis: if restenosis cannot be reliably 
determined, then it is unlikely that the associated 
risk factors will be identified. 
Restenosis Definition, New Concept. As a result 
of quantitative angiographic studies, a new con- 
cept for defining restcnosis criteria based on the 
change in minimal lumen diameter has been intro- 
duced. The changes in this value from post-PTCA 
to follow-up can be expected to give a good quan- 
titative measurement of the degree of restenosis. 
The restenosis criterion or the cutoff point divid- 
ing the restenosis patients from the nonrestenosis 
patient is then derived by determining the vari- 
ability of measurements (1 standard deviation of 
the difference in means) of the same lesion from 
separate catheterization sessions. Twice the vari- 
ability defines with reasonable certainty those le- 
sions that have undergone significant deteriora- 
tion from those that have not. We found this value 
to be 0.72 mm based on angiograms taken 90 days 
apart, whereas Nobuyoshi et  al. '* using a differ- 
ent measurement system, found 0.5 mm based 
on angiograms taken 7-10 days apart. However, 
criteria based on the absolute change in minimal 
luminal diameter are nevertheless limited be- 
cause they make no attempt to relate the extent 
of the restenosis process to the size of the vessel. 
Studies need to be undertaken to assess the var' 
ability of measurement on vessels with differen; 
diameters. "Sliding-scale'' criteria should be cre- 
ated, which adjust for vessel size. 
Restenosis Definition, a Categorical or Continu- 
ous Approach? In studies evaluating the biology 
of restenosis, a continuous measure of the degree 
of luminal obstruction is preferable since any pro- 
gression of the stenosis reflects the process of 
interest whether or  not an arbitrarily defined 
threshold of obstruction is reached. However, 
when the main concern is clinical decision mak- 
"PLACEBO" 
LOSS MLD = .40 
SD - S O  
I RESTENOSIS 
10.72 mm 
Figure 7. Gaussian model of restenosis rates in the reference group (upper panel) and in the treatment 
group (lower panel), considering a 30% reduction in minimal luminal diameter (MLD) change in the 
second group. The upper panel denotes the change in minimal lumen diamctcr found in a prospective 
study of our institutions." A change of 0.72 mm was taken as  the cutoff point for restenosis. This 
categorical model would mean 620 patients per group in order lo have a power of 90%. 
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ing, a binary or categorical measure of restenosis 
provides clinicians with more relevant informa- 
tion. Keeping in mind that an angiographic reste- 
nosis study assesses only the anatomical compo- 
nent of the restenosis problem, there is no thresh- 
old above which a loss of lurninal diameter would 
have clinically significant functional or sympto- 
matic consequences. Why then would one bother 
to try to define a threshold above which then 
would be “significant” quantitatively determined 
angiographic restenosis. To define the threshold 
on consideration of reproducibility of the mea- 
surement in individual patients is also questiona- 
ble. The possible benefit of a treatment (pharma- 
cological or interventional) can be measured with 
much greater precision by using the change in 
lumen diameter for the group. If treatment re- 
duces the loss of luminal diameter from 0.4 mm 
under to 0.25 rnm under active medica- 
tion, 233 patients per treatment group are re- 
quired in order to detect a significant difference 
with a power of 90%. The above reduction corre- 
sponds with restenosis rates (defined as a loss of 
minimal luminal diameter of 2 0.72 mm) of 25% 
and 17.5%, respectively (Fig. 7). This difference, 
however, can statistically be detected with a 
power of 90% with 620 patients per treatment 
group. Thus, statistically, the quantitative out- 
come determined from direct measurements of 
continuous variables can be evaluated with only 
one third of the number of patients required for 
the categorical outcome. This is indeed logical 
because the categorical end points do not take full 
advantage of the available information. Cur- 
rently, the results of six randomized trials, in- 
volving 76 cities and more than 2,500 patients, 
are analyzed at the quantitative angiographic core 
laboratory in Rotterdam and at the data center in 
Geneva. In the future you might expect that the 
quantitative angiographic results will be prc- 
sented according to a Gaussian model. Figure 8 
shows the distribution of the change in minimal 
lumen diameter (MLD) from postangioplasty to 6 
months follow-up angiography, excluding lesions 
No of lesions 
100 
\ 
\ 
-2 -1 0 1 2 3 
Change in MLD (mm) 
Figure 8. Distribution of the change in minimal lumen diameter (MLD) from postangioplasty angiogram to 
6 months follow-up angiography in 1,375 lesions, excluding lesions that had progressed to total occlusion at 
follow-up. The curve superimposed on the distribution depicts the theoretical Gaussian distribution given 
the mean and standard deviation of the population. A change > 0 corresponds with a decrease in MLD. 
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Figure 9. Cumulative distribution curvc of the change in minimal lumen diameter (MLD) from postan- 
gioplasty angiogram to follow-up angiography for the placebo and the treatment group in a restenosis 
prevention trial. 
that progressed to total occlusion. Superimposed 
is the theoretical Gaussian distribution curve, 
that the change in MLD approximately follows 
Arknn\i3/Pdgrnenfc We gratefully acknowledge the skillful 
sistance of Marie-Angele Morel in the preparation of the man- 
given the mean and standard deviation. It is clear secretarial assistance of Hanneke Roerade and technical as- 
this Gaussian distribution. Restenosis can thus be 
viewed as the tail end of an approximately Gaus- 
uscript. 
.. 
sian distributed phenomenon with some lesions 
crossing a more or less arbitrary cutoff point. A 
cumulative distribution curve of change in MLD 
is an elegant way of showing results of restenosis 
trials. Figure 9 shows this for a restenosis pre- 
vention trial with a Thromboxane Az receptor 
blocker. 
In summary, with the advent of new technol- 
ogy of quantitative assessing coronary lesions, 
one should fully exploit the quantitative informa- 
tion (angiographic or ultrasonic) available (i.e., 
continuous approach.) This is particularly impor- 
measured anatomical changes do not specifically 
relate to functional end points. 
1 .  
2 .  
3 .  
tant in view of the fact that the quantitatively 4. 
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